Funder
RCUK | Engineering and Physical Sciences Research Council
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference35 articles.
1. Sadelain M, Brentjens R, Rivière I, Park J. CD19 CAR therapy acute lymphoblastic Leukemia. Am Soc Clin Oncol Educ B. 2015;35:e360–e363. https://doi.org/10.14694/EdBook_AM.2015.35.e360.
2. Jackson HJ, Rafiq S, Brentjens RJ. Driving CAR T-cells forward. Nat Rev Clin Oncol 2016;13:370–383. https://doi.org/10.1038/nrclinonc.2016.36.
3. Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl J Med 2018;378:439–448. https://doi.org/10.1056/NEJMoa1709866.
4. Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N. Engl J Med 2017;377:NEJMoa1707447. https://doi.org/10.1056/NEJMoa1707447.
5. EMA. First two CAR-T cell medicines recommended for approval in the European Union [WWW Document]. 2018. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/06/news_detail_002983.jsp&mid=WC0b01ac058004d5c1. Accessed 10 Sept 18.
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献